CJ Whelan
Impact in
- Nephrology top 5%
- Parathyroid Disorders and Treatments
-
- Cardiovascular Function and Risk Factors
- Cardiomyopathy and Myosin Studies
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 9
-
- Parathyroid Disorders and Treatments 2
- Co-authors
- Philip N. Hawkins (9 shared papers)Marianna Fontana (3 shared papers)Julian D. Gillmore (2 shared papers)Helen J. Lachmann (7 shared papers)Ashutosh Wechalekar (1 shared paper)Daniel Sado (1 shared paper)James Moon (2 shared papers)Gaby Captur (1 shared paper)
- Journals
- Clinical Genetics (1 paper)Journal of Neurology (1 paper)HemaSphere (1 paper)Orphanet Journal of Rare Diseases (1 paper)European Heart Journal (1 paper)
- Partner nations
- United KingdomPakistanUnited States
In The Last Decade
CJ Whelan
9 papers receiving 305 citations
Peers
Comparison fields: 5 of 36
- Nephrology 110
- Cardiology and Cardiovascular Medicine 129
- Radiology, Nuclear Medicine and Imaging 108
- Molecular Biology 179
- Physiology 54
Countries citing papers authored by CJ Whelan
This map shows the geographic impact of CJ Whelan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by CJ Whelan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites CJ Whelan more than expected).
Fields of papers citing papers by CJ Whelan
This network shows the impact of papers produced by CJ Whelan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by CJ Whelan. The network helps show where CJ Whelan may publish in the future.
Co-authors
The 25 scholars most cited alongside CJ Whelan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 268 | |
| 2 | 2014 | 25 | |
| 3 | 2015 | 4 | |
| 4 | CTD versus Mel-Dex as upfront treatment in AL amyloidosis: a matched case-control study | 2010 | 3 |
| 5 | 2010 | 2 | |
| 6 | 2019 | 2 | |
| 7 | Assessment of Treatment Response in Cardiac AL Amyloidosis Using CMR Mapping - Results at 3 Months, 6 Months and 1 Year Post-Chemotherapy | 2018 | 1 |
| 8 | Rise in serum NT pro-BNP associated with chemotherapy in patients with AL amyloidosis: implications for organ response assessment | 2010 | 1 |
| 9 | 2014 | 1 |
About CJ Whelan
CJ Whelan is a scholar working on Molecular Biology, Nephrology, Neurology, Materials Chemistry and Surgery, having authored 9 papers that have together received 307 indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Lanthanide and Transition Metal Complexes (2 papers), Parathyroid Disorders and Treatments (2 papers), Sarcoidosis and Beryllium Toxicity Research (1 paper), Dermatological and Skeletal Disorders (1 paper), Connective tissue disorders research (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and Hepatitis C virus research (1 paper). The work is most often cited by research in Nephrology (110 citations), Cardiology and Cardiovascular Medicine (129 citations), Radiology, Nuclear Medicine and Imaging (108 citations), Molecular Biology (179 citations) and Physiology (54 citations). CJ Whelan has collaborated with scholars based in United Kingdom, Pakistan and United States. Frequent co-authors include Philip N. Hawkins, Marianna Fontana, Julian D. Gillmore, Helen J. Lachmann, Ashutosh Wechalekar, Daniel Sado, James Moon, Gaby Captur, Aviva Petrie and Sanjay M Banypersad. Their work appears in journals such as Clinical Genetics, Journal of Neurology, HemaSphere, Orphanet Journal of Rare Diseases and European Heart Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.